Etripamil for rapid heart rate in atrial fibrillation
Part of Heart & circulation clinical trials.
This trial tests a medication called etripamil to see if it can quickly slow down a rapid heart rate during episodes of atrial fibrillation. It may help people who have frequent, long-lasting episodes with a fast heartbeat.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have atrial fibrillation with a fast heart rate (at least 110 beats per minute).
- In the past year, you have had at least two episodes of atrial fibrillation that lasted 20 minutes or more and made you feel symptoms.
- You are on blood thinners or other medications to prevent clots, as recommended by your doctor.
- If you are a woman able to have children, you must have a negative pregnancy test and use effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a higher dose of magnesium (4 grams) compared to a lower dose (2 grams) or a placebo can help control a fast heart rate during atrial fibrillation. It may help patients who are already receiving diltiazem.
This study tests a new drug called BAY 3670549 to see if it can help convert atrial fibrillation (an irregular heartbeat) back to normal rhythm. You'll receive the study drug or a placebo along with a procedure to restore your heart's normal rhythm, and researchers will monitor how well it works and how safe it is.
This trial tests an early treatment approach for people who had a recent ischemic stroke (a stroke caused by a blocked blood vessel) and have an irregular heart rhythm called atrial fibrillation (AF). It aims to lower the chance of having another stroke by treating AF as early as possible after the stroke.
This study compares two different ablation procedures (treatments that target heart rhythm triggers) for people with atrial fibrillation and reduced heart pumping. It aims to see which approach works best and is safest for improving your heart rhythm when you also have heart failure.
This study tests a new catheter system, called Varipulse, to see if it's safe and effective for treating atrial fibrillation (AF), a heart rhythm problem. People with short-lasting AF who haven't been helped by medication may be able to join.
This trial tests two different medicines to slow a rapid heartbeat caused by atrial fibrillation or flutter. You will receive either an oral pill (bisoprolol) or intravenous (IV) medication (diltiazem) to see which works better and faster.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.